American Transplant Congress Annual Meeting Coverage
Patients discharged with home health or to a skilled nursing facility also were more likely to be readmitted.
At the end of a 22-year study period, the 1- and 3-year risk of graft loss did not differs significantly between black and white recipients.
Study reveals a 13% incidence of CIN in allograft recipients undergoing computed tomography or cardiac catheterization with contrast media.
A 30% decline in eGFR between 1 and 3 years post-transplant is associated with an increased risk of all-cause graft loss and patient death.
Study of renal transplant patients also shows that proton pump inhibitors are associated with increased arterial stiffness.
Recipients of diabetic donor kidneys—especially diabetic recipients—are at increased risk of graft loss and death.
Recipients of AKI kidneys have patient and graft survival rates similar to those of recipients of non-AKI kidneys.
Kidney recipients who lost the most weight prior to transplantation had a 25% decreased risk versus those with the most weight gain.
Recipients aged 65 years and older who receive kidneys from donors in the same age group have a higher risk of death and delayed graft function.
Death risk increased by 55% if patients are rehospitalized within 30 days of kidney transplantation.
Allograft function at one year post-transplant is more likely to be low if the donors are small.
Study finds a 60% increased likelihood of being hospitalized within 30 days of kidney transplant-related discharge.
Renal function improves over time in donors, declines with chronic kidney disease.
Reasons may include increasing prevalence of diabetes and obesity, economic disincentives, and transplant center oversight.
Systolic blood pressure of 160 mm Hg or higher raised death-censored graft loss risk twofold.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)